Author name: SpicyIP

(This post has been authored by our intern, Bhavik Shukla, a 5th year student at NLIU, Bhopal) Topical Highlight Namratha wrote about Cancer Patients Aid Association’s (‘CPAA’) call for revocation of Gilead’s Remdesivir, a drug being tested as a probable cure for COVID-19. She states that Remdesivir was granted a patent in India in February 2020, and that it has been touted as ‘essential’ for treatment of COVID-19 patients suffering from other serious health conditions simultaneously. She further notes that

(This post has been authored by our intern, Bhavik Shukla, a 5th year student at NLIU, Bhopal) Topical Highlight In an important and pertinent post, Namratha discussed the applicability of India’s fair use provisions to the use of copyrighted works for online education during the current COVID-19 pandemic. First, she notes that the scope of fair use under section 52(1)(i) of the Copyright Act is not merely limited to classroom teaching but to the entire process of education, including online

(This post has been authored by our intern, Bhavik Shukla, a 5th year student at NLIU, Bhopal) Topical Highlight Our Fellowship applicant, Anupriya discussed the copyright-related issues thrown up in light of the recent ‘Genda Phool’ row. She begins by stating that an absolute right to claim authorship exists under the Indian copyright law, and Badshah’s rendition of the song ‘Boroloker Biti Lo’ would be an infringement of Ratan Kahar’s exclusive rights over it. By way of policy implications, she